Abbreviations
From Cancer Guidelines Wiki
Clinical practice guidelines for the treatment of lung cancer > Abbreviations
Abbreviations
2G | Second generation |
3D | Three-dimensional |
3G | Third generation |
ACCP | American College of Chest Physicians |
ACP | Advance care planning |
ADLS | Activities of Daily Living Scale |
AI | Angiogenesis inhibitors |
ALK | Anaplastic lymphoma kinase |
ANITA | Adjuvant Navelbine International Trialist Association |
BAE | Bronchial artery embolisation |
BED | Biologically equivalent dose |
BTS | British Thoracic Society |
CAI | Carboxyaminotriazole |
CALGB | Cancer and Leukemia Group B trial group |
CBT | Cognitive Behaviour Therapy |
CHART | Continuous, hyperfractionated, accelerated radiotherapy |
CHARTWEL | CHART weekend-less |
CI | Confidence intervals |
CNS | Central nervous system |
COPD | Chronic obstructive pulmonary disease |
CPR | Cardio pulmonary resuscitation |
CRT | Chemoradiotherapy |
CT scan | Computed tomography scan |
CTV | Clinical Target Volume |
DRR | Digitally reconstructed radiographs |
DVHs | Dose volume histograms |
EBUS | Endo bronchial ultrasound |
EML4 | Echinoderm microtubule-associated protein-like 4 |
ECOG PS | Eastern Cooperative Oncology Group Performance Status |
EGFR | Epidermal growth factor receptor |
ENI | Elective nodal irradiation |
EORTC | European Organisation for Research and Treatment of Cancer |
FEV1 | Forced expiratory volume in one second |
FIS | Functional independent survival |
FNA | Fine needle aspiration |
GA | General anaesthesia |
GTV | Gross Tumour Volume |
HART | Hyperfractionated accelerated radiotherapy |
HR | Hazard ratio |
HRQOL | Health-related quality of life |
HVLT | Hopkins Verbal Learning Test |
IALT | International Adjuvant Lung cancer Trial |
ICC | Intercostal catheter |
IFRT | Involved field radiotherapy |
IHC | Immunohistochemistry |
IMRT | Intensity-modulated radiation therapy |
LACE | Lung adjuvant cisplatin evaluation |
LCNS | Lung Cancer Nurse Specialist |
LUNG ART | Lung Adjuvant Radiotherapy Trial |
MAb | Monoclonal antibody |
MCGP | Meaning Centered Group Psychotherapy |
MIR | Morphine Immediate release |
MLD | Mean total lung dose |
Mm/r | Morphine Modified release |
MMPs | Matrix metalloproteinases |
MMSE | Mini-mental status examination |
MPE | Malignant pleural effusion |
MRI | Magnetic resonance imaging |
NCCTG | North Central Cancer Treatment Group |
NNTB | Number needed to benefit |
NNH | Number needed to harm |
NNT | Number needed to treat |
NSAIDS | Non-steroidal anti-inflammatory drugs |
NSCLC | Non-small cell lung cancer |
OS | Overall survival |
PCI | Prophylactic cranial irradiation |
PD | Progressive disease |
PET scan | Positron emission tomography |
PFS | Progression free survival |
PORT | Postoperative external beam radiotherapy |
PS | Performance status |
PTV | Planning Target Volume |
QALY | Quality Adjusted Life Years |
QOL | Quality of life |
QUANTEC | Quantitative Analysis of Normal Tissue Effects in the Clinic |
RCT | Randomised controlled trial |
RFA | Radiofrequency ablation |
RR | Relative risk or Response rate |
RT | Radiotherapy |
RTOG | Radiation Therapy Oncology Group |
SABR | Stereotactic ablative radiotherapy |
SCC | Squamous cell carcinoma |
SCLC | Small cell lung cancer |
SCLC-LS | Small cell lung cancer - limited stage |
SCLC-ES | Small cell lung cancer - extensive stage |
SEER | Surveillance, Epidemiology and End Results |
SGP | Supportive group psychotherapy |
SMD | Standardised mean difference |
SRS | Stereotactic radiosurgery |
TAE | Transcathether arterial embolisation |
TKIs | Tyrosine kinase inhibitors |
TPC | Tunnelled pleural catheter |
VAS | Visual analogue scale |
VATS | Video-assisted thoracic surgery |
VEGF | Vascular endothelial growth factor |
WBRT | Whole brain radiotherapy |